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Many bacteria employ the nonmevalonate pathway for synthesis of isopentenyl diphosphate, the monomer
unit for isoprenoid biosynthesis. However, gram-positive cocci exclusively use the mevalonate pathway, which
is essential for their growth (E. I. Wilding et al., J. Bacteriol. 182:4319–4327, 2000). Enzymes of the mevalonate
pathway are thus potential targets for drug intervention. Uniquely, the enterococci possess a single open
reading frame, mvaE, that appears to encode two enzymes of the mevalonate pathway, acetoacetyl-coenzyme A
thiolase and 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase. Western blotting revealed that
the mvaE gene product is a single polypeptide in Enterococcus faecalis, Enterococcus faecium, and Enterococcus
hirae. The mvaE gene was cloned from E. faecalis and was expressed with an N-terminal His tag in Escherichia
coli. The gene product was then purified by nickel affinity chromatography. As predicted, the 86.5-kDa mvaE
gene product catalyzed both the acetoacetyl-CoA thiolase and HMG-CoA reductase reactions. Temperature
optima, Ha and Km values, and pH optima were determined for both activities. Kinetic studies of acetoacetyl-
CoA thiolase implicated a ping-pong mechanism. CoA acted as an inhibitor competitive with acetyl-CoA. A
millimolar Ki for a statin drug confirmed that E. faecalis HMG-CoA reductase is a class II enzyme. The
oxidoreductant was NADP(H). A role for an active-site histidine during the first redox step of the HMG-CoA,
reductase reaction was suggested by the ability of diethylpyrocarbonate to block formation of mevalonate from
HMG-CoA, but not from mevaldehyde. Sequence comparisons with other HMG-CoA reductases suggest that
the essential active-site histidine is His756. The mvaE gene product represents the first example of an
HMG-CoA reductase fused to another enzyme.
Isoprenoids, lipids synthesized from the 5-carbon isoprene
units of isopentenyl diphosphate, serve diverse and numerous
functions in all living organisms. Isopentenyl diphosphate is
formed by one of two pathways (14, 21), the mevalonate path-
way (Fig. 1) or the nonmevalonate pathway. Mammals and
archaea appear to use the mevalonate pathway exclusively,
whereas plants use both pathways (19).
Until recently, all bacteria were thought to use only the
nonmevalonate pathway. However, analysis of microbial ge-
nome sequences has revealed that the gram-positive cocci and
the spirochete Borrelia burgdorferi possess genes that encode
only enzymes of the mevalonate pathway (25), whereas a eu-
bacterial streptomycete strain appears to possess genes that
encode both pathways (13, 23). Genetic disruption experi-
ments have shown that the mevalonate pathway enzymes are
essential for the growth of gram-positive cocci (25). Genes
encoding enzymes of the mevalonate pathway are essential for
the growth of Staphylococcus aureus, and mutants auxotrophic
for mevalonate were severely attenuated for virulence in mice
(26).
In enterococci, the mevalonate pathway genes are clustered
at two positions on the genome, and, uniquely, two enzymes of
the mevalonate pathway appear to be encoded by a single
gene, mvaE (25). One enzyme is acetoacetyl-coenzyme A
(CoA) thiolase (acetyl-CoA C-acetyltransferase, EC 2.3.1.9),
the catalyst for the first reaction of the mevalonate pathway
(Fig. 1).
2 Acetyl-CoA™3acetoacetyl-CoA  CoASH (1)
Reaction 1 is freely reversible, and thiolysis (reaction 2) is
favored.
Acetoacetyl-CoA  CoASH™32 acetyl-CoA (2)
The second enzyme is 3-hydroxy-3-methylglutaryl (HMG)-
CoA reductase, the best-characterized enzyme of the meval-
onate pathway (3) and the target of the statin drugs that lower
human blood cholesterol levels (5). HMG-CoA reductase cat-
alyzes the rate-limiting step of the mevalonate pathway, the
reductive deacylation of (S)-HMG-CoA to (R)-mevalonate,
reaction 3 (Fig. 2). Reaction 3 involves successive formation of
enzyme-bound mevaldyl-CoA and mevaldehyde and proceeds
in three stages, the first and third of which are reductive.While
mevaldehyde is not released during the course of the reaction,
HMG-CoA reductase catalyzes two reactions of free mevalde-
hyde. Reaction 4 resembles the third stage, and reaction 5
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resembles the reverse of stages one and two of the overall
reaction. HMG-CoA reductase also catalyzes reaction 6, the
oxidative acylation of (R)-mevalonate to (S)-HMG-CoA.
Mevaldehyde  NADPH  H™3mevalonate  NADP (4)
Mevaldehyde  NADP  CoASH™3HMG-CoA  (5)
NADPH  H
Mevalonate  2 NADP  CoASH™3HMG-CoA  (6)
2 NADPH  2 H
There are two structural classes of HMG-CoA reductase
(2): the class I enzymes of eukarya and several archaea and
the class II HMG-CoA reductases of Pseudomonas mevalo-
nii (11), Archaeoglobus fulgidus (12), S. aureus (26), and some
streptomycetes (6, 23). Crystal structures of both classes of the
enzyme have been solved (10, 15). Relative to the class I
HMG-CoA reductases, those of class II are over four orders of
magnitude less sensitive to inhibition by statin drugs (1, 12, 26).
Enterococci are a major cause of nosocomial infections, and
Enterococcus faecalis is responsible for about 85% of all en-
terococcal infections. Since the mevalonate pathway is es-
sential for the survival of gram-positive cocci, the class II
HMG-CoA reductases, and potentially other enzymes of the
mevalonate pathway, represent potential targets for develop-
ment of active-site-directed inhibitors for use as antibiotics
against multiple-drug-resistant strains.
We report here the cloning of the mvaE gene of the gram-
positive pathogen E. faecalis, its expression in Escherichia coli,
and the purification and characterization of the gene product,
which exists in the enterococci examined as a true bifunctional
protein.
MATERIALS AND METHODS
Reagents. Purchased materials included deoxynucleoside triphosphates, T4
polynucleotide kinase, Ts-alkaline phosphatase, isopropyl--D-thiogalactopy-
ranoside (IPTG) and NuPAGE gels (Invitrogen), T4 DNA ligase and restriction
enzymes (New England Biolabs), Pwo polymerase (Roche Biochemicals), lyso-
zyme, mutanolysin, and immunoglobulin G horseradish peroxidase (Sigma). Ni-
nitrilotriacetic acid (NTA) agarose (Qiagen) was used for nickel affinity chro-
matography. Plasmid DNA preparations employed a QIAprep Spin Miniprep
Kit (Qiagen), and agarose gel extractions employed a Qiagen Gel Extraction kit.
Fluvastatin was a gift from Novartis. Antibodies against the E. faecalis fusion
protein were raised in New Zealand white rabbits by Covance Research Prod-
ucts, Denver, Pa. Western blotting employed the NOVEX NuPAGE System
(Invitrogen Corp.) and the ECL Western blotting system (Amersham Pharmacia
Biotech). Synthetic oligonucleotides were prepared, and automated DNA se-
quencing was performed in-house at GlaxoSmithKline. Unless otherwise speci-
fied, all other reagents were from Sigma.
Plasmids, bacterial strains, and culture media. Expression vector pET28a()
(Novagen) was modified to allow blunt cloning by replacing the NdeI site with
ScaI to generate pET28-6Hblunt. Bacterial strains used included E. coli DH5
and BL21(DE3) (Invitrogen), Enterococcus hirae (ATCC 8043), E. faecalis strain
41, and Enterococcus faecium H62738 (GlaxoSmithKline culture collection).
Genomic DNA from E. faecalis strain 41 was used for amplification of the mvaE
open reading frame. Luria-Bertani (LB) medium and agar (20) supplemented
with 50 g of kanamycin per ml served for the growth of E. coli strains. Tryptone
soy broth and agar or Todd Hewitt Broth supplemented with 5% (wt/vol) yeast
extract served for the growth of enterococcal strains.
Construction of the expression plasmid. The mvaE gene was PCR amplified
from E. faecalis genomic DNA by using a forward primer with the start codon
changed from TTG to ATG (5-ATGAAAACAGTAGTTATTATTGATGC-3)
and a reverse primer (5-ATGTTATTGTTTTCTTAAATCATTTAAAATAG
C-3). The resulting 2.4-kb fragment was phosphorylated, gel purified, and li-
gated into ScaI-digested pET28-6Hblunt that had been dephosphorylated and
gel purified (20). Plasmid DNA isolated from transformed E. coli DH5 cells was
sequenced to confirm the presence of unaltered mvaE. BL21(DE3) cells were
transformed with MvaEef-pET28-6Hblunt to express the N-terminally 6-His-
tagged protein.
Expression and purification of the gene product. E. coli BL21(DE3) cells
transformed with MvaEef–pET28-6Hblunt were grown initially at 37°C. Follow-
ing addition of 0.5 mM IPTG, growth was continued at 18°C. Harvested cells
were washed with 0.9% saline and were suspended in a solution containing 10
mM imidazole, 300 mM NaCl, 1 mM phenylmethylsulfonyl fluoride, 1 mM
FIG. 1. Intermediates and enzymes of the mevalonate pathway for
isopentenyl diphosphate biosynthesis.
FIG. 2. Substrates and products of the reaction catalyzed by HMG-CoA reductase (reaction 3). The putative enzyme-bound intermediates
mevaldyl-CoA and mevaldehyde are shown in brackets.
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dithiothreitol, 20 mM HEPES, pH 8.0 (Buffer A), and then were lysed in a
French press. The supernatant liquid obtained by centrifugation of the cell lysate
in a Beckman L8-70 ultracentrifuge (30,000 rpm, 60 min, 4°C) was applied to an
Ni-NTA column. The column was washed with Buffer A and then was eluted
successively with 50 and 100 mM imidazole in Buffer A. Fractions with high
activity were combined and stored at 70°C. The most active fractions contained
95% homogeneous His-tagged protein (Fig. 3). Overall yields averaged 10
mg/liter.
Preparation of enterococcal cell lysates and Western blotting. Proteins present
in extracts of E. faecalis, E. hirae, and E. faecium prepared with mutanolysin and
lysozyme were separated by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) and were transferred to polyvinylidene difluoride mem-
branes. Following incubation with rabbit antibody raised against the E. faecalis
mvaE gene product and incubation with rabbit immunoglobulin G horseradish
peroxidase, color was developed with diaminobenzidine tetrahydrochloride and
hydrogen peroxide.
Acetoacetyl-CoA thiolase activity. Determination of acetoacetyl-CoA thiolase
activity employed a Hewlett-Packard model 8452 diode array spectrophotometer
with the cell compartment maintained at 37°C to monitor the change in absor-
bance at 302 nm that accompanies the formation or thiolysis of acetoacetyl-CoA
(4). Standard assay conditions for each reaction studied follow: for reaction 1,
synthesis of acetoacetyl-CoA, 1 mM acetyl-CoA, 10 mM MgCl2, 50 mM Tris, pH
10.5; reaction 2, thiolysis of acetoacetyl-CoA, 30 M acetoacetyl-CoA, 100 M
CoA, 10 mM MgCl2, 50 mM Tris-HCl, pH 9.5. Both reactions were initiated by
addition of enzyme. Assays employed a final volume of 200 l. For both assays,
1 enzyme unit (eu) represents the synthesis or thiolysis in 1 min of 1 mol of
acetoacetyl-CoA. Reported data represent mean values for at least triplicate
determinations.
HMG-CoA reductase activity. Spectrophotometric assays of HMG-CoA
reductase activity at 37°C monitored the appearance or disappearance of
NADP(H) at 340 nm. Standard assay conditions for each reaction studied follow:
reaction 3, reductive deacylation of HMG-CoA to mevalonate, 0.4 mM NADPH,
1.0 mM (R,S)-HMG-CoA, 100 mM KCl, and 100 mM K xPO4, pH 6.5; reaction
4, reduction of mevaldehyde to mevalonate, 0.4 mM NADPH, 3.8 mM (R,S)-
mevaldehyde, 100 mM KCl, and 100 mM KxPO4, pH 7.0; reaction 5, oxidative
acylation of mevaldehyde to HMG-CoA, 3.0 mM NADP, 0.5 mM CoA, 2.5 mM
(R,S)-mevaldehyde, 100 mM KCl, 100 mM Tris-HCl, pH 9.3; reaction 6, oxida-
tive acylation of mevalonate to HMG-CoA, 3 mM NADP, 1.5 mM CoA, 4.5
mM (R,S)-mevalonate, 100 mM KCl, and 100 mM Tris-HCl, pH 8.0. Assays
employed a final volume of 200 l. Reactions were initiated by adding HMG-
CoA, mevaldehyde, or mevalonate. For all four assays, 1 eu represents the
turnover, in 1 min, of 1 mol of NADP(H). This corresponds to the turnover of
1 mol of mevaldehyde or 0.5 mol of HMG-CoA or mevalonate. Reported data
represent mean values for at least duplicate determinations.
RESULTS
The mvaE gene product is a true bifunctional protein. To
ascertain whether the mvaE gene product from a representa-
tive sample of enterococci undergoes posttranslational cleav-
age, cell lysates of E. faecalis, E. faecium, and E. hirae were
probed with antibodies against the E. faecalis mvaE gene prod-
uct (Fig. 4). The mvaE gene product was in all instances
present as a single peptide in vivo.
Expression and purification of the E. faecalis mvaE gene
product. Expression in E. coli of E. faecalis mvaE yielded a
single soluble polypeptide that was readily purified on a nickel-
chelating column. SDS-PAGE indicated that the product was
over 95% homogeneous and had a mass of approximately 90
kDa (Fig. 3, lane 1). The smaller peptides more prominent in
later fractions were recognized by Ni-NTA antibodies (Qia-
gen), and thus derive from the N terminus of the expressed
protein. The calculated molecular mass for the 803-residue
polypeptide encoded by mvaE is 86,496 Da. A mass of 88,712
Da estimated for the expressed protein by matrix-assisted laser
desorption ionization mass spectrometry, corresponds to the
peptide plus the 6-His tag and minus the N-terminal methio-
nine. Peptide sequencing of the purified protein confirmed that
this methionine had been removed and that the N-terminal
sequence was otherwise intact.
Described below are the kinetic properties of the two cata-
lytic activities, acetoacetyl-CoA thiolase and HMG-CoA re-
ductase.
Acetoacetyl-CoA thiolase. (i) Optimal temperature. Opti-
mum activity both for acetoacetyl-CoA synthesis and for thio-
lysis of acetoacetyl-CoA occurred at about 37°C (Fig. 5A). An
Arrhenius plot yielded an estimated Ha of 5.3 kcal for thio-
lysis of acetoacetyl-CoA (Fig. 5A, inset).
(ii) Optimal pH. Activity was optimal at pH 10.5 for aceto-
acetyl-CoA synthesis and at pH 9.5 for acetoacetyl-CoA thio-
lysis (Fig. 6A).
FIG. 3. SDS-PAGE of the expressed mvaE gene product purified
by nickel affinity chromatography. S, standards of the indicated mass.
Lane 1, early fractions of E. faecalis acetoacetyl-CoA thiolase/HMG-
CoA reductase. Numbers indicate molecular sizes in kilodaltons.
FIG. 4. The mvaE gene product is expressed as a fusion protein in
enterococci. Western blots of the indicated enterococcal lysates and of
the purified mvaE gene product are shown. Numbers indicate molec-
ular sizes in kilodaltons.
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(iii) Kinetic parameters. For catalysis of reaction 1, the
synthesis of acetoacetyl-CoA, the Km for acetyl-CoA was 0.60
mM (Table 1). For reaction 2, the rate of acetoacetyl-CoA
thiolysis was measured at several concentrations of CoA and of
acetoacetyl-CoA. A plot of 1/[CoASH] (CoASH is the reduced
form of CoA) versus 1/(specific activity) at several concentra-
tions of acetoacetyl-CoA yielded parallel lines, consistent with
a ping-pong mechanism (Fig. 7A). For acetoacetyl-CoA thio-
lysis, the Km for acetoacetyl-CoA was 88 M and the Km for
CoA was 10 M (Fig. 7A and inset). Table 1 summarizes these
kinetic parameters and compares them to those of other ace-
toacetyl-CoA thiolases.
(iv) Inhibition by CoA. CoA inhibited reaction 1 competitive
with acetyl-CoA. Ki was 0.12 mM and Ki/Km
AcCoA was 0.19
(Fig. 7B).
HMG-CoA reductase. (i) Optimal temperature. Optimal ac-
tivity for catalysis of reaction 3 occurred at 37°C. An Arrhenius
plot of selected data yielded a Ha of 14 kcal (Fig. 5B).
(ii) Coenzyme specificity. Nucleotide specificity has been
established for three class II HMG-CoA reductases. The
P. mevalonii enzyme uses NAD(H) exclusively (9), whereas
those of S. aureus (26) and A. fulgidus (12) use NAD(H) and
NADP(H) equally well. By contrast, E. faecalis HMG-CoA
reductase was specific for NADP(H) as the oxidoreductant for
all four catalyzed reactions. Activity was undetectable with
NAD(H), and even a 10-fold excess of NADH over NADPH
did not inhibit reaction 3.
(iii) Optimal pH. The effect of hydrogen ion concentration
on the rates of all four catalyzed reactions was determined.
Optimal activity was observed at pH 6.5 and 7.0 for reductive
reactions 3 and 4 (Fig. 6B) and at pH 8.0 and 9.5 for oxidative
reactions 5 and 6 (Fig. 6C).
(iv) Kinetic parameters. Kinetic parameters were deter-
mined for all four catalyzed reactions. Table 2 compares these
data to those for other characterized HMG-CoA reductases.
(v) Inhibition by a statin drug. Inspection of sequence align-
ments suggested that the E. faecalis enzyme is a class II HMG-
CoA reductase. A major difference between the two classes of
HMG-CoA reductase is their sensitivity to inhibition by statin
drugs. Ki values for statins are in the millimolar range for the
FIG. 5. Effect of temperature on activity. Assays were conducted at the indicated temperatures under otherwise standard conditions. (A) Re-
action 2, thiolysis of acetoacetyl-CoA; (B) reaction 3, reductive deacylation of HMG-CoA to mevalonate. The insets are selected data shown as
Arrhenius plots.
FIG. 6. Effect of hydrogen ion concentration on activity. All assays were conducted in a solution containing 50 mM sodium acetate, 50 mM
glycine, 50 mM Tris, 50 mM 2-(N-morpholino)ethanesulfonic acid at the indicated pH under otherwise standard conditions. (A) Reaction 1,
synthesis of acetoacetyl-CoA (F), and reaction 2, thiolysis of acetoacetyl-CoA (E); (B) reaction 3, reductive deacylation of HMG-CoA to
mevalonate (), and reaction 4, reduction of mevaldehyde to mevalonate (); (C) reaction 5, oxidative acylation of mevaldehyde to HMG-CoA
({), and reaction 6, oxidative acylation of mevalonate to HMG-CoA (}).
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class II enzymes and in the nanomolar range for the class I
enzymes (12, 26). Fluvastatin inhibited reaction 3 competitive
with HMG-CoA with a Ki of 0.5 mM (Fig. 8). A Ki of 0.2 to 0.5
mM is diagnostic of a class II HMG-CoA reductase (7, 26).
(vi) Inactivation by diethylpyrocarbonate and reactivation
by hydroxylamine hydrochloride. In all HMG-CoA reductases
studied to date, a histidine plays a key role in catalysis, proto-
nation of the CoA thioanion released during the first stage of
the overall reaction (9). The active-site histidine appears to
participate exclusively in the first stage of reaction 3 (7, 8). We
therefore asked whether the histidine-modifying reagent dieth-
ylpyrocarbonate (DEPC) inactivated E. faecalis HMG-CoA
reductase. DEPC blocked the reductive deacylation of HMG-
CoA to mevalonate, and subsequent treatment with hydroxyl-
amine hydrochloride restored HMG-CoA reductase activity
(Fig. 9A). By contrast, under conditions where the catalysis of
reaction 3 was severely attenuated, DEPC had no detectable
effect on reaction 4, the reduction of mevaldehyde to meval-
onate (Fig. 9B).
DISCUSSION
Analysis of complete and partial genome sequences for
pathogenic eubacteria revealed the presence of genes thought
to encode enzymes of the mevalonate pathway of isopentenyl
diphosphate biosynthesis. Subsequent inspection of sequence
alignments revealed an unusual feature of isopentenyl diphos-
phate biosynthesis in enterococci, the presence of the mvaE
gene that appears to encode, without interruption, both ace-
toacetyl-CoA thiolase and HMG-CoA reductase on a single
polypeptide (25). Western blotting of enterococcal extracts was
employed to show that the mvaE gene product is indeed ex-
pressed in E. faecalis, E. faecium, and E. hirae as a fusion
protein and is not posttranslationally cleaved. Radish seedlings
express an acetoacetyl-CoA thiolase/HMG-CoA synthase fu-
sion protein (24). However, the mvaE gene product represents
the first bifunctional enzyme of isopentenyl diphosphate bio-
FIG. 7. Acetoacetyl-CoA thiolase proceeds via a ping-pong mechanism. (A) Acetoacetyl-CoA thiolysis (reaction 2). Assays employed the
indicated concentrations of CoA and either 11 (F), 23 (E), 34 (), or 45 M () acetoacetyl-CoA. Inset: the Y intercepts were plotted versus the
reciprocal of acetoacetyl-CoA concentration. (B) CoA competes with acetyl-CoA during synthesis of acetoacetyl-CoA. The reaction employed 0
(F), 30 (E), or 60 mM () CoA, the indicated concentrations of acetyl-CoA, and otherwise standard conditions.
















E. faecalis 85 600 1,250 88 10
Z. ramigera (17) 71 1,200 810 15 9.0
Bradyrhizobium japonicum (22) NR 100 NR 19 30
Chicken liver cytosol (4) NR 270 NR 39 6.4
a Data for the synthesis and thiolysis of acetoacetyl-CoA are shown.
b NR, not reported.

































a The ranges of reported Km values for HMG-CoA reductases from different
sources are given.
b For either NADP(H) or NAD(H).
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synthesis in eubacteria and the first example of HMG-CoA
reductase fused to another protein.
The kinetic properties of E. faecalis acetoacetyl-CoA thio-
lase resemble those of previously characterized forms of the
enzyme (Table 1). A plot of 1/(specific activity) versus 1/[ace-
toacetyl-CoA] and inhibition of acetoacetyl-CoA synthesis by
CoA suggested that reactions 1 and 2 proceed via a ping-pong
mechanism. Prior investigations have established the partici-
pation of an acyl-cysteinyl intermediate and roles for a histi-
dine and a second cysteine as proton acceptors and donors
during catalysis by acetoacetyl-CoA thiolase (17). Inspection of
multiple sequence alignments suggested that the cognates of
the acyl-acceptor Cys89Z, His348Z, and Cys278Z of Zoogloea
ramigera acetoacetyl-CoA thiolase are Cys88E, His342E, and
Cys372E of the E. faecalis enzyme, respectively. (Subscripts on
residue numbers refer to the enzymes from E. faecalis [E] and
Z. ramigera [Z]).
The sequence-based inference that E. faecalis HMG-CoA
reductase is a class II enzyme was confirmed by the 0.5 mM Ki
value for inhibition of reaction 3 by the statin drug fluvastatin.
This Ki value is diagnostic of a class II enzyme (1, 12). As for
both classes of the enzyme, inhibition was competitive with
HMG-CoA. As anticipated for an enzyme from a mesophile,
the temperature optimum was 37°C. The calculated activation
energy Ha of 14 kcal is similar to the Ha of 13 kcal for
A. fulgidus HMG-CoA reductase (12), suggesting that the
same step is rate limiting for both enzymes. All four reac-
tions catalyzed by HMG-CoA reductase exclusively em-
ployed NADP(H) as the coenzyme. Activity with NAD(H) was
below detectable limits, and even a 10-fold molar excess of
NAD(H) over NADP(H) did not inhibit reaction 3. The class
II HMG-CoA reductase of P. mevalonii uses NAD(H) (11),
and those of S. aureus (26) and A. fulgidus (12) use either
NAD(H) or NADP(H). The E. faecalis enzyme is thus pres-
ently the only known class II HMG-CoA reductase that is
specific for NADP(H).
As previously shown for P. mevalonii HMG-CoA reductase
(7), exposure of the fusion protein to the histidine-modifying
reagent DEPC severely attenuated catalysis of reaction 3, and
subsequent treatment with hydroxylamine hydrochloride re-
stored activity. By contrast, DEPC had no effect on reaction 4.
Since hydroxylamine hydrochloride removes the ethoxyformyl
group from histidyl but not from cysteinyl or lysyl residues (16),
no catalytically critical cysteinyl or lysyl residue had been mod-
ified. These observations implicate a histidine essential for
catalysis of reaction 3 but nonessential for reaction 4. This
FIG. 8. Inhibition by a statin drug of reaction 3, the reductive
deacylation of HMG-CoA to mevalonate. Assays were conducted in
the presence of 0 (E) or 500 M (F) fluvastatin at the indicated
concentrations of HMG-CoA under otherwise standard conditions. All
reactions were initiated by adding NADPH.
FIG. 9. Effect of DEPC and subsequent addition of hydroxylamine hydrochloride on HMG-CoA reductase activity. (A) Effect on reaction 3,
the reductive deacylation of HMG-CoA to mevalonate. Treatment with DEPC and with hydroxylamine hydrochloride was conduced on ice.
Samples contained fusion protein in a solution containing 250 mM KCl, 10% (vol/vol) glycerol, 250 mM K xPO4, pH 6.5. DEPC in ethanol was
added to a concentration of 0.8 (}) or 8.0 mM (F). A control contained ethanol but no DEPC (E). After 40 min, hydroxylamine hydrochloride,
pH 6.5, was added to a concentration of 700 mM (arrow). Ten-microliter portions removed at the indicated times were assayed for the ability to
catalyze reaction 3, the reductive deacylation of HMG-CoA to mevalonate. Ao and A are the specific activities at zero time and at the indicated
times, respectively. (B) Effect on reaction 4, the reductive deacylation of mevaldehyde to mevalonate. Reaction conditions were as described above
but at pH 7.0 and using 8 mM DEPC and an ethanol control (). Data for reaction 4 () are shown. Also shown are data for reaction 3 (F),
included to establish that reaction with DEPC had indeed occurred.
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inference is consistent with the proposed role of a histidine
that protonates the CoA thioanion released during the first
stage of reaction 3 (7–9). Sequence comparisons suggest that
the active-site histidine of E. faecalis HMG-CoA reductase is
His756E (Fig. 10).
Characterized acetoacetyl-CoA thiolases are either dimers
or tetramers (17), whereas HMG-CoA reductases typically are
either tetramers (10) or hexamers (15, 18). Gel filtration chro-
matography and analytical ultracentrifugation suggest that the
mvaE gene product exists as a complex mixture of high-mo-
lecular-weight species (Hedl et al., unpublished observations).
Our future investigations will address the effect of multimeric
state on catalytic activity.
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